Compare OSPN & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSPN | BIOA |
|---|---|---|
| Founded | 1991 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 561.7M | 481.0M |
| IPO Year | 2000 | 2024 |
| Metric | OSPN | BIOA |
|---|---|---|
| Price | $18.23 | $6.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $18.00 | ★ $35.63 |
| AVG Volume (30 Days) | 491.9K | ★ 814.9K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.89% | N/A |
| EPS Growth | 28.77 | ★ 66.21 |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $243,180,000.00 | $8,995,000.00 |
| Revenue This Year | $2.90 | N/A |
| Revenue Next Year | $2.36 | $106.14 |
| P/E Ratio | $37.52 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.07 | $5.05 |
| 52 Week High | $18.83 | $25.96 |
| Indicator | OSPN | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 59.90 | 26.14 |
| Support Level | $17.05 | N/A |
| Resistance Level | $18.28 | $8.53 |
| Average True Range (ATR) | 0.54 | 0.40 |
| MACD | -0.04 | 0.08 |
| Stochastic Oscillator | 67.61 | 14.57 |
OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. The company build secure, seamless, and trusted digital experiences through two solution portfolios: Cybersecurity solutions engaged in protecting identities, securing mobile apps, and safeguarding access through high-assurance authentication, threat intelligence, fraud prevention, and robust mobile app protection, defending users, devices, and applications against sophisticated attacks, while Digital agreement solutions focuses on streamlining workflows with secure e-signatures, identity verification, and smart digital forms, built to enable speed, compliance and other customer experiences.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.